NCT06733428

Brief Summary

To evaluate the performance of pachymetry function

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
108

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 10, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

December 13, 2024

Completed
27 days until next milestone

Study Start

First participant enrolled

January 9, 2025

Completed
19 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 28, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 28, 2025

Completed
Last Updated

February 4, 2025

Status Verified

January 1, 2025

Enrollment Period

19 days

First QC Date

December 10, 2024

Last Update Submit

January 31, 2025

Conditions

Eye AbnormalitiesNormal Eyes

Outcome Measures

Primary Outcomes (1)

  • Cornea thickness

    thickness of the cornea

    1 day

Study Arms (3)

Normal

Subjects with healthy cornea

Device: Pachymeter

Cornea

Subjects with abnormal cornea

Device: Pachymeter

Glaucoma

Subjects with glaucoma

Device: Pachymeter

Interventions

PachymeterDEVICE

Measure the thickness of the cornea

Also known as: TRK-3 auto kerato-refracto tonometer
CorneaGlaucomaNormal

Eligibility Criteria

Age22 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Subjects seeing an eye doctor that have normal cornea, cornea abnormality, or glaucoma

You may qualify if:

  • Provide voluntary written consent
  • Age at least 22 years old
  • For glaucoma group only, visual field defect and optic nerve damage consistent with glaucoma
  • For cornea group only, cornea abnormality

You may not qualify if:

  • Ocular condition that may affect ability to perform cornea measurements
  • Have or is suspected to have ocular infection
  • Unable to tolerate eye testing

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Illinois College of Optometry

Chicago, Illinois, 60616, United States

Location

MeSH Terms

Conditions

Eye Abnormalities

Condition Hierarchy (Ancestors)

Eye DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 10, 2024

First Posted

December 13, 2024

Study Start

January 9, 2025

Primary Completion

January 28, 2025

Study Completion

January 28, 2025

Last Updated

February 4, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations

US(1)